Author

admin

Browsing

Investor Insight InMed is a pharmaceutical drug development company advancing proprietary small-molecule drugs in Alzheimer’s and ophthalmology, backed by a revenue-generating manufacturing subsidiary. The company is an undervalued opportunity with cash exceeding market capitalization and multiple upcoming catalysts. Overview InMed Pharmaceuticals (NASDAQ:INM) is a biopharmaceutical company with a differentiated business…

Ukrainian President Volodymyr Zelenskyy announced new efforts to ‘clean up’ the nation’s energy sector amid a corruption scandal and near-constant attacks from Russia. Zelenskyy met with Ukrainian Prime Minister Yulia Svyrydenko on Sunday morning, saying he called on lawmakers to revamp the leadership at the State Nuclear Regulatory Inspectorate and…